{'Year': '2019', 'Month': 'Jun'}
International survey of patients undergoing percutaneous coronary intervention and their attitudes toward pharmacogenetic testing.
To evaluate perceptions toward pharmacogenetic testing of patients undergoing percutaneous coronary intervention (PCI) who are prescribed dual antiplatelet therapy (DAPT) and whether geographical differences in these perceptions exist.